Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Cervicogenic Headache: early-phase trial registry

2 of 5 indexed Cervicogenic Headache trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Cervicogenic Headache: 5 US clinical trials tracked, 2 recruiting.

Cervicogenic Headache is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Franklin Pierce University, running 1 of these trials.

Enrollment posture brief

Registry condition cervicogenic-headache

OPEN 2 | RECR 40% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Cervicogenic Headache (this)40%
Open-enrollment share among volume-matched conditions near Cervicogenic Headache

Cervicogenic Headache lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cervicogenic Headache on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cervicogenic Headache is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cervicogenic Headache research.

    Franklin Pierce University accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Cervicogenic Headache trials plan to enrol fewer than 100 people.

    Median target enrolment is 48 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.

  4. Cervicogenic Headache research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Cervicogenic Headache records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Landmark-Based Greater Occipital Nerve Block Procedure
1 trials
Ultrasound Guided Greater Occipital Nerve Block at C2 Procedure
1 trials
Non-Thrust Mobilizations Other
1 trials
Thrust Mobilization Other
1 trials
SPRINT Peripheral Nerve Stimulation (PNS) System Device
1 trials
Osteopathic Manipulative Therapy and Exercise Therapy Combination
1 trials
Exercise,Non-thrust Mobilization Other
1 trials
Dry Needling,Thrust Manipulation Other
1 trials

US sites by state

Facility locations filed on Cervicogenic Headache trials. A trial with sites in several states counts in each.

Minnesota 2 trials
Utah 1 trials
Texas 1 trials
Pennsylvania 1 trials
North Carolina 1 trials
Michigan 1 trials
Massachusetts 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cervicogenic Headache page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cervicogenic Headache condition card totals 5 registered trials; most-linked intervention Landmark-Based Greater Occipital Nerve Block; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.